Clinical Trials Logo

Rabies Virus clinical trials

View clinical trials related to Rabies Virus.

Filter by:
  • None
  • Page 1

NCT ID: NCT03145766 Completed - Rabies Virus Clinical Trials

Immunogenicity and Safety of a Purified Vero Rabies Vaccine

Start date: April 17, 2017
Phase: Phase 2
Study type: Interventional

This multicenter, observer-blind, controlled, randomized, Phase II study was designed to evaluate different formulations of the Purified Vero Rabies Cell vaccine VRVg.

NCT ID: NCT01339312 Completed - Rabies Clinical Trials

Study of the Purified Vero Rabies Vaccine - Serum Free in Comparison With the Reference Purified Vero Rabies Vaccine

Start date: April 2011
Phase: Phase 3
Study type: Interventional

This study is designed to gather safety and immunogenicity data with Purified Vero Rabies Vaccine - Serum Free (VRVg), when given in a post-exposure prophylaxis vaccination schedule, using the Essen regimen, across different populations. Primary Objective: - To demonstrate that VRVg is at least as immunogenic as the reference vaccine, Verorab vaccine, in terms of proportion of participants with a rabies virus neutralizing antibody titer ≥ 0.5 IU/mL at Day 14, i.e., before the fourth vaccination, in participants aged 10 to 17 years and in participants aged 18 years and over. Secondary Objectives: - To assess the clinical safety of VRVg after each vaccination when administered in a post-exposure prophylaxis vaccination schedule in each respective age group and overall - To describe the immune response induced by VRVg before the fourth vaccination and 14 days after the last vaccination in each respective age groups and overall.